共 496 条
[1]
Abaza Y(2017)Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab Blood 129 1275-1283
[2]
Kantarjian H(2016)Acute promyelocytic leukemia: preventing early complications and late toxicities Hematol Am Soc Hematol Educ Progr 2016 10-15
[3]
Garcia-Manero G(2017)Predictors of thrombohemorrhagic early death in children and adolescents with Ann Hematol 96 1449-1456
[4]
Estey E(2015)(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy Lancet Oncol 16 1295-1305
[5]
Borthakur G(1981)Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial Med Pediatr Oncol 9 5-15
[6]
Jabbour E(2013)Acute promyelocytic leukemia in children Eur J Haematol 91 483-489
[7]
Faderl S(2018)Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience Leukemia 32 1671-1678
[8]
O'Brien S(2020)Molecular remission as a therapeutic objective in acute promyelocytic leukemia Children (Basel) 7 11-561
[9]
Wierda W(2015)Advances in pediatric acute promyelocytic leukemia Blood Cancer J 5 e304-3473
[10]
Pierce S(1990)Acute promyelocytic leukemia: where did we start, where are we now, and the future Nature 347 558-1377